Published in Respirology on June 01, 2005
Risk factors and outcomes associated with chronic obstructive pulmonary disease exacerbations requiring hospitalization. Can Respir J (2009) 1.70
Risk factors of hospitalization and readmission of patients with COPD exacerbation--systematic review. Int J Chron Obstruct Pulmon Dis (2007) 1.67
Effect of exacerbations on health status in subjects with chronic obstructive pulmonary disease. Health Qual Life Outcomes (2009) 0.88
Effectiveness and cost-effectiveness of early assisted discharge for chronic obstructive pulmonary disease exacerbations: the design of a randomised controlled trial. BMC Public Health (2010) 0.86
Risk factors of hospitalization and readmission of patients with COPD in Hong Kong population: analysis of hospital admission records. BMC Health Serv Res (2011) 0.86
Clinical, humanistic, and economic burden of chronic obstructive pulmonary disease (COPD) in Canada: a systematic review. BMC Res Notes (2015) 0.82
Long term effects of an integrated care intervention on hospital utilization in patients with severe COPD: a single centre controlled study. Respir Res (2015) 0.81
Pharmacogenetics of chronic obstructive pulmonary disease: challenges and opportunities. Pharmacogenomics (2010) 0.80
General practitioners' home visit tendency and readmission-free survival after COPD hospitalisation: a Danish nationwide cohort study. NPJ Prim Care Respir Med (2014) 0.79
Outcomes associated with acute exacerbations of chronic obstructive pulmonary disorder requiring hospitalization. Lung India (2015) 0.77
Comorbidity as a contributor to frequent severe acute exacerbation in COPD patients. Int J Chron Obstruct Pulmon Dis (2016) 0.75
American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med (2006) 5.65
Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med (2007) 5.51
An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med (2013) 4.49
Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. Can Respir J (2007) 4.27
Effects of home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med (2008) 4.12
A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial. Ann Intern Med (2012) 4.10
Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care. Can Respir J (2008) 3.67
An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med (2012) 3.62
Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease--2003. Can Respir J (2003) 3.14
Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest (2015) 2.32
Self-management programmes for COPD: moving forward. Chron Respir Dis (2012) 2.07
Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med (2008) 1.90
Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. Am J Respir Crit Care Med (2007) 1.85
Effect of an action plan with ongoing support by a case manager on exacerbation-related outcome in patients with COPD: a multicentre randomised controlled trial. Thorax (2011) 1.82
A cohort study showed that health insurance databases were accurate to distinguish chronic obstructive pulmonary disease from asthma and classify disease severity. J Clin Epidemiol (2005) 1.76
A Canadian, multicentre, randomized clinical trial of home-based pulmonary rehabilitation in chronic obstructive pulmonary disease: rationale and methods. Can Respir J (2005) 1.63
Effects of written action plan adherence on COPD exacerbation recovery. Thorax (2010) 1.57
Inhaled corticosteroids in COPD: determinants of use and trends in patient persistence with treatment. Can Respir J (2004) 1.55
Relationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review. Respir Res (2011) 1.51
Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med (2002) 1.47
Increased expression of ADAM33 and ADAM8 with disease progression in asthma. J Allergy Clin Immunol (2007) 1.40
State of the Art Compendium: Canadian Thoracic Society recommendations for the management of chronic obstructive pulmonary disease. Can Respir J (2004) 1.35
Implementing practice guidelines: a workshop on guidelines dissemination and implementation with a focus on asthma and COPD. Can Respir J (2006) 1.32
Canadian Thoracic Society COPD Guidelines: summary of highlights for family doctors. Can Respir J (2003) 1.25
Living with chronic obstructive pulmonary disease: a survey of patients' knowledge and attitudes. Respir Med (2009) 1.24
Importance of viral and bacterial infections in chronic obstructive pulmonary disease exacerbations. J Clin Virol (2009) 1.20
Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline. Can Respir J (2011) 1.20
Optimizing pulmonary rehabilitation in chronic obstructive pulmonary disease--practical issues: a Canadian Thoracic Society Clinical Practice Guideline. Can Respir J (2010) 1.10
CD8 positive T cells express IL-17 in patients with chronic obstructive pulmonary disease. Respir Res (2011) 1.07
Components of the COPD Assessment Test (CAT) associated with a diagnosis of COPD in a random population sample. COPD (2012) 1.04
Canadian practice assessment in chronic obstructive pulmonary disease: respiratory specialist physician perception versus patient reality. Can Respir J (2013) 1.02
Early administration of systemic corticosteroids reduces hospital admission rates for children with moderate and severe asthma exacerbation. Ann Emerg Med (2012) 0.99
The mitochondrial phenotype of peripheral muscle in chronic obstructive pulmonary disease: disuse or dysfunction? Am J Respir Crit Care Med (2008) 0.98
The impact of obesity on walking and cycling performance and response to pulmonary rehabilitation in COPD. BMC Pulm Med (2010) 0.97
Cigarette smoke increases TLR4 and TLR9 expression and induces cytokine production from CD8(+) T cells in chronic obstructive pulmonary disease. Respir Res (2011) 0.96
Clinical relevance of diagnosing COPD by fixed ratio or lower limit of normal: a systematic review. COPD (2013) 0.94
Home-based pulmonary rehabilitation in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med (2010) 0.93
Major care gaps in asthma, sleep and chronic obstructive pulmonary disease: a road map for knowledge translation. Can Respir J (2013) 0.92
Executive summary: prevention of acute exacerbation of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest (2015) 0.91
Measurement of health preferences among patients with tuberculous infection and disease. Med Decis Making (2002) 0.91
Action Plan to enhance self-management and early detection of exacerbations in COPD patients; a multicenter RCT. BMC Pulm Med (2009) 0.91
A comparison of the efficacy and safety of once-daily fluticasone furoate/vilanterol with twice-daily fluticasone propionate/salmeterol in moderate to very severe COPD. Eur Respir J (2013) 0.91
The Canadian Optimal Therapy of COPD Trial: design, organization and patient recruitment. Can Respir J (2004) 0.91
The Oort structural equation modeling approach detected a response shift after a COPD self-management program not detected by the Schmitt technique. J Clin Epidemiol (2009) 0.90
Bronchodilator responsiveness and reported respiratory symptoms in an adult population. PLoS One (2013) 0.89
Detecting exacerbations using the Clinical COPD Questionnaire. Health Qual Life Outcomes (2010) 0.87
Heat awareness and response among Montreal residents with chronic cardiac and pulmonary disease. Can J Public Health (2009) 0.87
Focusing the focus group: impact of the awareness of major factors contributing to non-adherence to acute paediatric asthma guidelines. J Eval Clin Pract (2010) 0.87
TNFα antagonists for acute exacerbations of COPD: a randomised double-blind controlled trial. Thorax (2012) 0.86
Altered mitochondrial regulation in quadriceps muscles of patients with COPD. Clin Physiol Funct Imaging (2010) 0.86
Autophagy in locomotor muscles of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 0.86
Respiratory infection: how important is oral health? Curr Opin Pulm Med (2003) 0.86
Walking exercise response to bronchodilation in mild COPD: a randomized trial. Respir Med (2012) 0.86
Pneumonia risk with inhaled fluticasone furoate and vilanterol compared with vilanterol alone in patients with COPD. Ann Am Thorac Soc (2015) 0.85
A self-management education program including an action plan for acute COPD exacerbations. COPD (2009) 0.84
Pulmonary rehabilitation in Canada: A report from the Canadian Thoracic Society COPD Clinical Assembly. Can Respir J (2015) 0.83
Fatigue in COPD: prevalence and effect on outcomes in pulmonary rehabilitation. Chron Respir Dis (2011) 0.82
Combining both generic and disease-specific properties: development of the McGill COPD quality of life questionnaire. COPD (2011) 0.81
[Canadian Thoracic Society COPD guidelines: summary of highlights for family doctors]. Can Respir J (2004) 0.81
Adherence to pediatric asthma guidelines in the emergency department: a survey of knowledge, attitudes and behaviour among health care professionals. Can Respir J (2010) 0.81
Quality assurance of spirometry in a population-based study -predictors of good outcome in spirometry testing. COPD (2014) 0.81
Paced-walk and step tests to assess exertional dyspnea in COPD. COPD (2009) 0.81
Eccentric cycle exercise in severe COPD: feasibility of application. COPD (2011) 0.80
How do COPD patients respond to exacerbations? BMC Pulm Med (2011) 0.80
Obesity in chronic obstructive pulmonary disease: is fatter really better? Can Respir J (2014) 0.79
Evaluating nocturnal oxygen desaturation in COPD--revised. Respir Med (2011) 0.79
Facilitating education in pulmonary rehabilitation using the living well with COPD programme for pulmonary rehabilitation: a process evaluation. BMC Pulm Med (2013) 0.78
Cycling efficiency is not compromised for moderate exercise in moderately severe COPD. Med Sci Sports Exerc (2007) 0.77
[Canadian Thoracic Society COPD guidelines: summary of highlights for family doctors]. Can Respir J (2003) 0.77
Do we know the minimal clinically important difference (MCID) for COPD exacerbations? COPD (2013) 0.77
Disease management for COPD: avoiding hospitalizations and controlling cost? COPD (2011) 0.77
Detecting improvements in dyspnea in COPD using a three-minute constant rate shuttle walking protocol. COPD (2012) 0.77
Validation of a new questionnaire with generic and disease-specific qualities: the McGill COPD Quality of Life Questionnaire. Can Respir J (2012) 0.76
The effects of a multisite aerobic exercise intervention on asthma morbidity in sedentary adults with asthma: the Ex-asthma study randomised controlled trial protocol. BMJ Open (2013) 0.75
Integrating the care of the complex COPD patient. Monaldi Arch Chest Dis (2017) 0.75
A Novel Method of Estimating Small Airway Disease Using Inspiratory-to-Expiratory Computed Tomography. Respiration (2017) 0.75
Moving from strategy to implementation… first steps. Can Respir J (2015) 0.75
We asked... you told. Can Respir J (2015) 0.75
Teaching time for metered-dose inhalers in the emergency setting. Chest (2002) 0.75
Does dynamic hyperinflation impair submaximal exercise cardiac output in chronic obstructive pulmonary disease? Clin Invest Med (2006) 0.75
Isokinetic muscle function in COPD. Chest (2002) 0.75
Preventing hospitalizations for COPD exacerbation: early pulmonary rehabilitation? Respirology (2011) 0.75
The means to match our ambitions. Can Respir J (2014) 0.75